Dr. Hussein Tawbi: Opdualag Clinical Trial Updates
In March of 2022, the melanoma community celebrated the FDA approval of nivolumab + relatlimab (brand name Opdualag), a new treatment for patients with metastatic melanoma that combines two different immunotherapies, nivolumab and relatlimab, into one medicine.
Combating Melanoma Brain Metastases and Leptomeningeal Disease
Melanoma is the third most common source of brain metastases, exceeded only by lung and breast cancer. In addition, metastatic melanoma cells have the highest propensity for settling in the brain out of any solid tumor.
2024 Scientific Retreat & Patient Forum Scholarship
7 September 2023 In Events
MRA’s Patient Advocate Scientific Retreat & Patient Forum Scholarship encourages the engagement, education, and inclusion of patient advocates in melanoma research by providing support for their attendance at the Annual Melanoma Exchange Patient Forum and Scientific Retreat.
MRA's Latest Research Report: Reaching for the Stars
Each year, MRA convenes global thought leaders from across the melanoma research community to exchange ideas, report on scientiﬁc successes and challenges, and network and forge new collaborations.
How Biomarkers Are Used in Melanoma
The term “biomarker” is a frequent buzz word in cancer care circles, but many patients do not understand what a biomarker is and how they are used in the clinic. At the MRA 2022 Patient Forum, Dr. David Polsky of New York University took away much of the mystery surrounding biomarkers by deftly explaining what they are and how they enter the market, as well as by showing how physicians use biomarkers to guide therapy and predict outcomes in their patients.
Melanoma Awareness Month: In Case You Missed It
Last month, the entire melanoma community came together to recognize Melanoma Awareness Month, hear from leaders in the field, connect with other advocates, and spread awareness of melanoma and the importance of prevention and early detection.
Tackling Treatment-Resistant Disease
The melanoma field has made incredible progress over the past decade in its ability to treat patients with advanced melanoma. This includes patients with tumors that cannot be entirely removed by surgery and patients whose tumors have spread to other parts of the body, referred to as metastatic melanoma.
Make a Difference this Melanoma Awareness Month
By Renee Orcione, MRA Digital Engagement & Communications Manager | 24 April 2023 In Allies & Partnerships, Events, Prevention
Melanoma Awareness Month, held each May, is an opportunity to join forces with other melanoma advocates to raise awareness of melanoma, the importance of early detection, and the many ways to practice sun safety. MRA has an exciting month of activities planned - and we hope you can join us! Read more to learn about all the ways you can get involved and make a difference this Melanoma Awareness Month.
Trust Your Gut & Other Tips for Facing Melanoma
Whether new to melanoma or well into your journey — as a patient, survivor, or caregiver — practical tips, strategies, and advice were shared at the 2022 MRA Melanoma Exchange Patient and Advocate Forum. Speakers at the Forum discussed what types of providers to seek, how to find information about your disease, how to advocate...
Recordings from MRA's 2023 Patient Forum
MRA’s 2023 Patient Forum brought together melanoma patients, survivors, advocates, and their loved ones to provide lay-friendly, state-of-the-science education and promote collaboration.